NCT03659799View on ClinicalTrials.gov

Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 12, 2019

Primary Completion Date

December 31, 2022

Study Completion Date

March 30, 2023

Conditions
Type 1 Diabetes Mellitus
Interventions
DRUG

Insulin FiAsp

An insulin bolus of FiAsp will be given 5 minutes before breakfast

DRUG

Insulin Aspart

An insulin bolus of Aspart will be given 5 minutes before breakfast

OTHER

60-minutes postprandial exercise

A 60-minute exercise at 60% of VO2 peak will be performed 60 minutes after breakfast

OTHER

120-minutes postprandial exercise

A 60-minute exercise at 60% of VO2 peak will be performed 120 minutes after breakfast

Trial Locations (1)

H2W 1R7

Institut de recherches cliniques de Montréal, Montreal

All Listed Sponsors
lead

Institut de Recherches Cliniques de Montreal

OTHER

NCT03659799 - Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes | Biotech Hunter | Biotech Hunter